Genky DrugStores Co., Ltd.

9267.T
Pharmaceutical Retailers
2026/09/25 10:48 Updated
Market Cap: $676.2M (¥106.5B)
Stock Price: $22.16 (¥3,490)
Exchange Rate: 1 USD = ¥157.48

Notice of Issuance of Stock Options (Stock Acquisition Rights)

Grant of 100,000 shares worth of stock options to 204 directors within the company and directors/employees of subsidiaries. Exercise period: October 1, 2028 to September 30, 2033. Total number of grant units: 1,000, with 100 shares per unit.

Importance:
Page Updated: September 22, 2026
IR Disclosure Date: September 10, 2026

Key Figures

  • Total stock acquisition rights: 1,000 units
  • Number of granted shares: 100 shares/units
  • Number of recipients: 204 people

AI要約

Background and overview of stock option issuance

Based on the board resolution, we will issue stock options to internal directors and directors/employees of our subsidiary. The objective is to improve consolidated performance and boost morale and business expansion. The target number of shares is 100,000, the total number of grant units is 1,000, and each unit grants 100 shares.

Exercise conditions, period, and adjustments

The exercise period for the stock options is from October 1, 2028 to September 30, 2033, with the last day being the preceding business day on non-business days of the shareholder register administrator. The exercise price is determined using the market closing price, with adjustments for stock splits and consolidations, and for declines in market value. Exercise conditions include service requirements and inheritance by succession, and acquisition upon transfer requires board approval.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Genky DrugStores Co., Ltd.

Company overview · Stock price · Financial data · All IR

View company page →